# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Ovarian cancer

Cancer, Ovarian
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 81-90 of 2566 results.
An Efficacy and Safety Study of MORAb-003 in Platinum-Resistant or Refractory Relapsed Ovarian Cancer
Status: Terminated
Last Changed: Mar 30, 2017
First Received: Aug 20, 2008
Disease(s): Ovarian Cancer
Intervention(s): MORAb-003 (farletuzumab), 0.9% Saline, Paclitaxel
Locations: Southern Cancer Center, Mobile, Alabama, United States
St. Joseph's Hospital and Medical Center, Phoenix, Arizona, United States
California Cancer Care, Inc., Greenbrae, California, United States
Moores UC San Diego Cancer Center, La Jolla, California, United States
USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States
... and 57 other locations.
Long Term Survivors in Ovarian Cancer
Status: Terminated
Last Changed: Jun 07, 2019
First Received: Apr 25, 2017
Disease(s): Ovarian Cancer
Intervention(s): Retrospective, cross-sectional descriptive analysis
Locations: University Medical Center Groningen, Groningen, Netherlands
Clinical Pre-screening Protocol for Ovarian Cancer
Status: Recruiting
Last Changed: May 14, 2019
First Received: Mar 18, 2019
Disease(s): Ovarian Cancer
Intervention(s): Drug Response Predictor® (DRP)
Locations: Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Slowed Carboplatin Infusion for Ovarian Cancer Patients Receiving Carboplatin Re-Treatment
Status: Terminated
Last Changed: Dec 08, 2016
First Received: Jan 14, 2014
Disease(s): Recurrent Ovarian Cancer, Platinum Sensitive Ovarian Cancer
Intervention(s): Carboplatin
Locations: Massachusetts General Hospital, Boston, Massachusetts, United States
ROCKIF Trial: Re-sensitization of Carboplatin-resistant Ovarian Cancer With Kinase Inhibition of FAK
Status: Recruiting
Last Changed: Jan 27, 2020
First Received: Sep 19, 2017
Disease(s): Ovarian Cancer
Intervention(s): VS-6063, Paclitaxel, Carboplatin
Locations: University of California San Diego, San Diego, California, United States
Trial of Pimasertib With SAR245409 or Placebo in Ovarian Cancer
Status: Completed
Last Changed: Dec 12, 2018
First Received: Sep 06, 2013
Disease(s): Ovarian Cancer
Intervention(s): Pimasertib once daily, Pimasertib placebo, SAR245409 placebo, SAR245409, Pimasertib twice daily
Locations: Research site, Augusta, Georgia, United States
Research site, Chicago, Illinois, United States
Research site, Indianapolis, Indiana, United States
Research site, Silver Spring, Maryland, United States
Research site, Boston, Massachusetts, United States
... and 30 other locations.
Live After an Epithelial Ovarian Cancer: Multidisciplinary Assessment of Effects and Long-term Remission in Patients Needs.
Status: Completed
Last Changed: Feb 10, 2017
First Received: Dec 23, 2014
Disease(s): Epithelial Ovarian Cancer
Intervention(s): Gynecological consultation
Locations: CHU, Besançon, France
Institut Bergonie, Bordeaux, France
Polyclinique Bordeaux Nord, Bordeaux, France
CHU, Caen, France
Centre François Baclesse, Caen, France
... and 14 other locations.
Sentinel Lymph Node in Early Ovarian Cancer
Status: Completed
Last Changed: Oct 18, 2019
First Received: Mar 02, 2018
Disease(s): Ovarian Cancer
Intervention(s): sentinel node technique
Locations: Hospital Universitario y Politécnico La Fe, Valencia, Spain
NGR-hTNF in Combination With an Anthracycline in Platinum-resistant Ovarian Cancer (NGR018)
Status: Completed
Last Changed: Jan 15, 2019
First Received: Jan 15, 2019
Disease(s): Ovarian Cancer
Intervention(s): NGR-hTNF, Pegylated liposomal doxorubicin, Doxorubicin
Locations: Ospedale San Raffaele, Milan, Italy
Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
Istituto Europeo di Oncologia, Milan, Italy
Istituto Nazionale Tumori IRCCS Fondazione "Giovanni Pascale", Naples, Italy
Detection of Ovarian Cancer Using an Artificial Intelligence Enabled Transvaginal Ultrasound Imaging Algorithm
Status: Not yet recruiting
Last Changed: Jan 02, 2020
First Received: Jan 02, 2020
Disease(s): Ovarian Cancer
Intervention(s): Artificial Intelligence Enabled Transvaginal Ultrasound Imaging algorithm